| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RxSight, Inc. | Director | Common Stock | 30.3K | $1.85M | $61.09 | Jun 6, 2024 | Direct |
| AEON Biopharma, Inc. | Director, 10%+ Owner | Stock Option | 16.3K | Mar 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RXST | RxSight, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| AEON | AEON Biopharma, Inc. | Mar 19, 2024 | 1 | $0 | 4 | Mar 21, 2024 | Director, 10%+ Owner |
| AEON | AEON Biopharma, Inc. | Aug 14, 2023 | 1 | $0 | 4 | Aug 16, 2023 | Director, 10%+ Owner |
| RXST | RxSight, Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Director |
| RXST | RxSight, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| RXST | RxSight, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | Director |
| RXST | RxSight, Inc. | Aug 3, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Director |